NEWARK, N.J.--(BUSINESS WIRE)--Urovalve, a medical device company focused on creating products for urinary flow and control, announced today that it has received $400,000 in new funding from the National Institutes of Health (NIH) to advance development of its Surinate® Bladder Management System—designed to improve the quality of life of men who suffer from acute or chronic urinary retention, an inability to empty the bladder.
